Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALAN L TANNENBAUM

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1235117342
CMS profile
100502
Location
CAPE CORAL, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$748.07

34 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $748.07 34

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALAN L TANNENBAUM

NPI 1235117342 · CMS profile ID 100502

Allopathic & Osteopathic Physicians / Internal Medicine

CAPE CORAL, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1235117342?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALAN L TANNENBAUM, NPI 1235117342, CMS profile ID 100502. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1235117342?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ALAN L TANNENBAUM, NPI 1235117342, CMS profile ID 100502. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1235117342?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ALAN L TANNENBAUM, NPI 1235117342, CMS profile ID 100502, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1235117342?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

34 matching records · $748.07 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 34 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–34 of 34.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $21.8412/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796135915 CMS
Janssen Pharmaceuticals, Inc $3.5411/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788015009 CMS
Merck Sharp & Dohme Corporation $17.0411/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848643795 CMS
Merck Sharp & Dohme Corporation $52.7211/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848351971 CMS
Janssen Pharmaceuticals, Inc $5.2311/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788015007 CMS
AstraZeneca Pharmaceuticals LP $117.0111/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829845765 CMS
GlaxoSmithKline, LLC. $14.7810/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803026333 CMS
Novo Nordisk Inc $18.2810/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811008031 CMS
Merck Sharp & Dohme Corporation $17.7609/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848662077 CMS
Indivior Inc. $15.9308/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835086609 CMS
AstraZeneca Pharmaceuticals LP $11.4908/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829766269 CMS
Novo Nordisk Inc $14.8208/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811722059 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.7908/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763669410 CMS
Merck Sharp & Dohme Corporation $11.2707/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848524793 CMS
Janssen Pharmaceuticals, Inc $3.8307/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788015001 CMS
Medtronic, Inc. $17.3507/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827282077 CMS
Novartis Pharmaceuticals Corporation $15.4906/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813305671 CMS
Janssen Pharmaceuticals, Inc $105.4506/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788014997 CMS
Merck Sharp & Dohme Corporation $15.4205/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848457877 CMS
Novo Nordisk Inc $18.8405/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811346914 CMS
Janssen Pharmaceuticals, Inc $29.4705/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788014999 CMS
GlaxoSmithKline, LLC. $15.8604/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803076831 CMS
Merck Sharp & Dohme Corporation $19.5104/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848507807 CMS
Janssen Pharmaceuticals, Inc $1.7804/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788015003 CMS
Novartis Pharmaceuticals Corporation $14.9104/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813305667 CMS
Merck Sharp & Dohme Corporation $20.6303/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848322695 CMS
Janssen Pharmaceuticals, Inc $17.0603/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788015005 CMS
Lilly USA, LLC $11.7203/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818919255 CMS
Novo Nordisk Inc $18.1603/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811722057 CMS
GlaxoSmithKline, LLC. $13.2602/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802894371 CMS
Merck Sharp & Dohme Corporation $18.0801/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848520627 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.5701/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763669412 CMS
Novo Nordisk Inc $19.8601/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811201877 CMS
Novo Nordisk Inc $15.3201/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811346907 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,610.23 24
PY2020 $786.44 21
PY2021 $748.07 34
PY2022 $348.10 14
PY2023 $435.38 12
PY2024 $977.80 21
PY2025 $472.84 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $3,050.00 2
PY2021 Principal investigator $800.00 1
PY2020 Principal investigator $19,787.02 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $1,250.00 10/22/2024 Non-covered Recipient Entity
Vanguard Clinical Research
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation No dispute reported 06/30/2026 1128706407
Principal investigator 1 SANOFI US SERVICES INC. $1,800.00 10/21/2024 Non-covered Recipient Entity
Pharmaseek LLC
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation No dispute reported 06/30/2026 1128718373